cidofovir prodrugs (TSRL)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namecidofovir prodrugs (TSRL)
Drug Alias Name(L)-Tyr-NH-C16H33-cidofovirD-Val-Ser-CO2iPr-HPMPC(L)-Tyr-NH-C16H33-HPMPCcidofovir prodrugs (TSRL)TSR-243 +[7] 
ClassificationSmall molecules > Prodrug > Directed prodrug therapySmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus InfectionsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTherapeutic Systems Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesTherapeutic Systems Research Laboratories
Inactive CompaniesN/A
Active IndicationsCytomegalovirus InfectionsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A